NetraMark is an AI and pharma-tech company, has developed proprietary solutions for pharmaceutical and biotechnology companies.
NetraMark has raised $2.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2026.
NetraMark's investors include Creative Destruction Lab.
NetraMark is headquartered in Toronto, Canada.
NetraMark is an AI and pharma-tech company, has developed proprietary solutions for pharmaceutical and biotechnology companies.
NetraMark is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NetraMark — Funding & Investors." VCBacked, January 13, 2026, https://www.vcbacked.co/company/netramark. Accessed August 14, 2026.
VCBacked. (2026). NetraMark — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/netramark
{{cite web |title=NetraMark — Funding & Investors |url=https://www.vcbacked.co/company/netramark |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated